Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: The role of CD56bright NK cells in neurodegenerative disorders

Fig. 2

Differences in marker expression between CD56bright NK cells and CD56dim NK cells. Under homeostatic conditions, CD56bright NK cells and CD56dim NK cells express a variety of activation, functional and migratory markers that can be used to differentiate them, but also to explain their different locations and functions. In general, CD56bright NK cells express higher levels of immunoregulatory proteins, such as tumor necrosis factor (TNF), interferon-γ (IFN-γ), granzyme K, natural killer group (NKG)2A, natural cytotoxicity receptors (NCR), and they express the trimeric high-affinity receptors for IL-2. In contrast, CD56dim NK cells express the dimeric low-affinity receptor for IL-2 and higher levels of cytotoxic proteins, such as granzyme B and perforin. With regards to chemokine receptors, CD56bright NK cells express C–C chemokine receptors (CCR)2, CCR5, CCR7, C–X–C motif chemokine receptor (CXCR)3, and CXCR4, while CD56dim NK cells express CXCR1, CX3CR1, chemokine receptor (ChemR)23, and sphingosine-1-phosphate receptor 5 (S1P5), and low levels of CXCR3 and CXCR4. Furthermore, CD56bright NK cells generally express higher levels of adhesion molecules lymphocyte function-associated antigen 2 (LFA-2) and CD62L (L-selectin), whereas CD56dim NK cells preferentially express LFA-1 [59, 60, 65]. Both subsets express similar levels of very late antigen-4 (VLA-4) [61]. However, the expression of chemotactic receptors and adhesion molecules can be strongly affected by external stimuli

Back to article page